Dr. Oluwayemisi Love Adejumo, MD

Dr. Adejumo practices at Alameda Health System - Highland Hospital in Oakland, California, part of Alameda County.

Dr. Adejumo's NPI, 1699031179, was assigned on April 9, 2012. Dr. Adejumo graduated from UVA School of Medicine in 2012. Dr. Adejumo holds California license A168063.

Dr. Adejumo's primary practice is Alameda Health System - Highland Hospital, at 1411 East 31st Street, Oakland, CA 94602 in Alameda County. The practice phone is (510) 437-4800.

Dr. Adejumo's primary practice is Alameda Health System - Highland Hospital in Oakland, California, part of Alameda County. Dr. Adejumo is also affiliated with Alta Bates Summit Medical Center. The medical group on file is Alameda Health System. Dmand AI also links Dr. Adejumo to 3 more hospitals, 2 medical groups, 1 community health center and 1 group practice or clinic, each named with a free account. Dr. Adejumo's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Adejumo practices, 7 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Adejumo's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Adejumo is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Adejumo's licenses on file in 3 states: California, New York and Michigan.

Dmand AI lists angioplasty and cardiac catheterization among the conditions Dr. Adejumo treats.

CMS data shows 2,018 Medicare services from Dr. Adejumo across 20 procedure codes in 2024, for 1,304 Medicare patients. Medicare paid $39,862 for them.

CMS counts 1,304 Medicare patients who saw Dr. Adejumo in 2024. The largest group is 65 to 74, with 572 patients. 75% of them have high blood pressure, and 63% have high cholesterol. 86% are also on Medicaid. Their average risk score is 2.36, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Adejumo's median patient age at 60, with 45% women.

In 2024, Dr. Adejumo wrote 659 Medicare Part D claims for 135 patients. 80% of them were for generic drugs. CMS names the drug for 588 of them, across 16 drugs with 11 or more claims each, at $186,960 in total drug cost. In 2023, CMS named 364 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Adejumo for performance year 2024, reported as part of a group. Dr. Adejumo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Adejumo, published from 2013 to 2020. 2020 was the busiest year, with 3. Dr. Adejumo's most frequent co-authors are Amir Allak, MD, Hooman Kamel, MD and Alexander E. Merkler.

CMS Open Payments shows 154 general payments to Dr. Adejumo from 23 drug and device companies from 2016 to 2025. Grants make up the largest share, 75% of the total. Medtronic Vascular, Inc. paid the most, $18,803.

Dr. Adejumo graduated from UVA School of Medicine in 2012. Dr. Adejumo is a member of SCAI.

Dr. Adejumo is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.